Anna Pomés1, Martin D Chapman2, Sabina Wünschmann2. 1. Indoor Biotechnologies, Inc., 700 Harris Street, Charlottesville, VA, 22903, USA. apomes@inbio.com. 2. Indoor Biotechnologies, Inc., 700 Harris Street, Charlottesville, VA, 22903, USA.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to evaluate the most recent findings on indoor allergens and their impact on allergic diseases. RECENT FINDINGS: Indoor allergens are present inside buildings (home, work environment, school), and given the chronic nature of the exposures, indoor allergies tend to be associated with the development of asthma. The most common indoor allergens are derived from dust mites, cockroaches, mammals (including wild rodents and pets), and fungi. The advent of molecular biology and proteomics has led to the identification, cloning, and expression of new indoor allergens, which have facilitated research to elucidate their role in allergic diseases. This review is an update on new allergens and their molecular features, together with the most recent reports on their avoidance for allergy prevention and their use for diagnosis and treatment. Research progress on indoor allergens will result in the development of new diagnostic tools and design of coherent strategies for immunotherapy.
PURPOSE OF REVIEW: The purpose of this review is to evaluate the most recent findings on indoor allergens and their impact on allergic diseases. RECENT FINDINGS: Indoor allergens are present inside buildings (home, work environment, school), and given the chronic nature of the exposures, indoor allergies tend to be associated with the development of asthma. The most common indoor allergens are derived from dust mites, cockroaches, mammals (including wild rodents and pets), and fungi. The advent of molecular biology and proteomics has led to the identification, cloning, and expression of new indoor allergens, which have facilitated research to elucidate their role in allergic diseases. This review is an update on new allergens and their molecular features, together with the most recent reports on their avoidance for allergy prevention and their use for diagnosis and treatment. Research progress on indoor allergens will result in the development of new diagnostic tools and design of coherent strategies for immunotherapy.
Authors: C Almqvist; M Wickman; L Perfetti; N Berglind; A Renström; M Hedrén; K Larsson; G Hedlin; P Malmberg Journal: Am J Respir Crit Care Med Date: 2001-03 Impact factor: 21.405
Authors: Geoffrey A Mueller; Lori L Edwards; Jim J Aloor; Michael B Fessler; Jill Glesner; Anna Pomés; Martin D Chapman; Robert E London; Lars C Pedersen Journal: J Allergy Clin Immunol Date: 2010-03-11 Impact factor: 10.793
Authors: Charlotte Nicholas; Ganesa Wegienka; Suzanne Havstad; Edward Zoratti; Dennis Ownby; Christine Cole Johnson Journal: Ann Allergy Asthma Immunol Date: 2010-09 Impact factor: 6.347
Authors: Marja Rytkönen-Nissinen; Soili Saarelainen; Jukka Randell; Jukka Häyrinen; Nisse Kalkkinen; Tuomas Virtanen Journal: Allergy Asthma Immunol Res Date: 2015-03-05 Impact factor: 5.764
Authors: Jon R Konradsen; Takao Fujisawa; Marianne van Hage; Gunilla Hedlin; Christiane Hilger; Jörg Kleine-Tebbe; Elizabeth C Matsui; Graham Roberts; Eva Rönmark; Thomas A E Platts-Mills Journal: J Allergy Clin Immunol Date: 2014-10-03 Impact factor: 10.793
Authors: Ameya U Amritwar; Christopher A Lowry; Lisa A Brenner; Andrew J Hoisington; Robert Hamilton; John W Stiller; Teodor T Postolache Journal: Curr Treat Options Allergy Date: 2017-03-25
Authors: Shao Lin; Wayne R Lawrence; Ziqiang Lin; Melissa Francois; Iulia A Neamtiu; Qiaoxuan Lin; Eva Csobod; Eugen S Gurzau Journal: Int Arch Occup Environ Health Date: 2017-06-09 Impact factor: 3.015
Authors: Teresa Stemeseder; Bettina Schweidler; Patrick Doppler; Eva Klinglmayr; Stephanie Moser; Lisa Lueftenegger; Martin Himly; Roland Lang; Joerg Zumbach; Gertie J Oostingh; Thomas Hawranek; Arne C Bathke; Gabriele Gadermaier Journal: PLoS One Date: 2017-01-03 Impact factor: 3.240